Home / Stocks / Manipal Health Enterpri L
MANIPALHOS

Manipal Health Enterpri L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹696.45

Change

+7.6 (1.1%)

Open

₹692.7

Prev. Close

₹688.85

Day High

₹699.95

Day Low

₹680.0

Volume Analysis

Traded

1,097,963

Delivered

929,911

Delivery %

84.69%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (25.0%)

Weaknesses (0)

No signal for this stock

Opportunities (2)

  • •Strong 3-year EPS growth (26.0%)
  • •Strong 3-year revenue growth (29.1%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹724.21 ₹712.08 ₹704.26 ₹692.13 ₹684.31 ₹672.18 ₹664.36
Fibonacci ₹712.08 ₹704.46 ₹699.75 ₹692.13 ₹684.51 ₹679.8 ₹672.18
Camarilla ₹701.94 ₹700.11 ₹698.28 ₹692.13 ₹694.62 ₹692.79 ₹690.96

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

+2.95%

1 Month

+10.98%

3 Months

-2.64%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹146.98

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

5.52%

Net margin 8.87% × asset turnover 0.36x × equity multiplier 1.73x

Company Overview

Sector

Healthcare

Market Cap

₹89,630 Cr

P/E (TTM)

95.6

ROE

12.7%

Book Value

₹127.0

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Manipal Health Enterpri L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 64/100. The strongest factor is Growth (100/100), while Valuation (16/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (25.0%). Strong 3-year EPS growth (26.0%).

TopFund Score — Fundamentals Quality

64/100 — Average

Data confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

89

Growth

100

Valuation

16

Cash Flow

88

Corporate Governance

50

Momentum

39

Institutional Ownership

16

Business Quality

68

Risk & Volatility

63

Liquidity

98

From Screener.in

  • +Company has delivered good profit growth of 76.8% CAGR over last 5 years
  • −Though the company is reporting repeated profits, it is not paying out dividend

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Earnings call audio for Q2/H1 FY2026 unaudited results uploaded on November 13, 2026.

Manipal Health completed acquisition of Kinder Women’s Hospital and Fertility Centre on November 13, 2026.

CARE Ratings quarterly IPO monitoring report shows nil deviation; Rs 5,727.04 crore utilized by September 30, 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2025 Sep 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 2,238 2,475 2,882 3,091 3,399
Expenses + 1,651 1,804 2,191 2,354 2,527
Operating Profit 586 672 691 737 872
OPM % 26.0% 27.0% 24.0% 24.0% 26.0%
Other Income + 30 53 27 59 5
Interest 132 156 289 293 300
Depreciation 141 151 185 187 205
Profit before tax 344 418 244 315 372
Tax % 26.0% 24.0% 24.0% 23.0% 23.0%
Net Profit + 254 318 187 243 285
EPS in Rs 2 3 2 2 2
Raw PDF — — — — —
YoY Sales growth — — — 38 37

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Sales + 1,813 3,975 4,806 6,172 8,242 10,336
Expenses + 1,483 3,054 3,527 4,489 6,115 7,725
Operating Profit 330 921 1,279 1,683 2,127 2,611
OPM % 18.0% 23.0% 27.0% 27.0% 26.0% 25.0%
Other Income + -47 293 -48 -86 134 111
Interest 205 326 329 455 512 864
Depreciation 183 256 315 397 507 680
Profit before tax -105 632 586 745 1,242 1,178
Tax % 30.0% 14.0% 27.0% 28.0% 13.0% 22.0%
Net Profit + -138 542 429 533 1,082 917
EPS in Rs -1 5 4 5 9 8
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sales growth — 119 21 28 34 25

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 1,064 2,732 3,166 3,940 5,770 8,190 16,444
Borrowings + 1,575 2,017 2,184 5,130 6,385 12,863 8,081
Other Liabilities + 1,316 2,521 2,337 1,612 1,658 3,446 4,182
Total Liabilities 4,024 7,346 7,763 10,757 13,890 24,735 28,970
Fixed Assets + 2,278 4,582 4,784 8,158 9,826 18,753 19,283
CWIP 412 1,089 1,033 42 614 795 1,369
Investments 551 768 1,038 1,121 1,776 2,675 2,813
Other Assets + 784 907 908 1,436 1,675 2,511 5,504
Total Assets 4,024 7,346 7,763 10,757 13,890 24,735 28,970
Equity Capital 69 76 76 76 77 236 263

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 426 805 1,149 1,389 1,570 2,078
Cash from Investing Activity + -188 -1,711 -994 -846 -2,544 -7,025
Cash from Financing Activity + -280 941 -144 -250 904 4,954
Net Cash Flow -42 34 12 293 -70 8
Free Cash Flow 334 629 823 1,062 520 767
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 106 98 105 100 87 96

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

  Sep 2026
Public 17.23%
Promoters 72.08%
Government 0.21%
FII 3.51%
DII 6.97%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Manipal Health Enterpri L (this stock) 89,630 95.6 5.36 12.7%
Lupin Limited 89,994 16.0 3.75 28.7%
Max Healthcare Ins Ltd 99,557 70.1 8.82 14.7%
Aurobindo Pharma Ltd 104,215 25.7 2.64 10.1%
Glenmark Pharmaceuticals 73,937 36.5 6.59 23.6%
Mankind Pharma Limited 108,424 46.5 6.16 13.1%
Cipla Ltd 112,563 36.2 3.18 11.6%

Which Mutual Funds Hold Manipal Health Enterpri L?

Frequently Asked Questions about Manipal Health Enterpri L

Community Sentiment

What are other investors saying about Manipal Health Enterpri L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.